What question did this study set out to answer?

Investigate the role and regulatory mechanisms of vascular endothelial growth factor (VEGF) in the development of cardiac allograft arteriosclerosis.

May 28, 2002Circulation

Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis

View Full Paper

Ask AI

Bookmark

Why the study?

Does VEGF signaling modulate the development of cardiac allograft arteriosclerosis in animal models?

Population

Rat cardiac allografts and cholesterol-fed rabbits with cardiac allografts

Comparison

Blockade of signaling downstream of VEGF… vs Control allografts (implied)

Design

Preclinical

Authors

KLKarl LemströmUniversity of Helsinki RKR. KrebsUniversity of Helsinki ANAntti I. NykänenUniversity of Helsinki

Discussion

Member takes

Implication

VEGF signaling may promote cardiac allograft arteriosclerosis in animals; leaves open whether receptor blockade could prevent chronic rejection in human recipients.

Key Points

Investigate the role and regulatory mechanisms of vascular endothelial growth factor (VEGF) in the development of cardiac allograft arteriosclerosis.
Assessed VEGF mRNA and protein expression alongside intimal thickening in rat cardiac allografts, evaluating the impact of downstream VEGF receptor signaling inhibition.
Administered intracoronary adenoviral vectors encoding mouse VEGF164 into cardiac allografts of cholesterol-fed rabbits to observe arteriosclerotic lesion progression.
Alloimmune responses induced VEGF expression in cardiomyocytes and infiltrating inflammatory cells, showing a strong positive correlation between intragraft VEGF protein levels and intimal thickening.
Downstream blockade of VEGF receptor signaling significantly reduced arteriosclerotic lesion formation in rat allografts.
Adenoviral delivery of VEGF164 enhanced arteriosclerotic lesion progression in cholesterol-fed rabbits, driven by increased intimal macrophage infiltration and neovascularization.

Structured PICO

Does VEGF signaling modulate the development of cardiac allograft arteriosclerosis in animal models?

Population

Rat cardiac allografts and cholesterol-fed rabbits with cardiac allografts

Intervention

Blockade of signaling downstream of VEGF receptor (in rats) or intracoronary perfusion with a clinical-grade adenoviral vector encoding mouse VEGF(164) (in rabbits)

Comparator

Control allografts (implied)

Outcome

Formation of arteriosclerotic lesions (intimal thickening)surrogate

VEGF plays a positive regulatory role in the formation of coronary arteriosclerotic lesions in cardiac allografts, suggesting it as a potential therapeutic target.

Cite This Study

Lemström et al. (2002) studied this question.

synapsesocial.com/papers/6a8a8b2b5c4c6b099dec9d3b https://doi.org/10.1161/01.cir.0000016821.76177.d2

Topics

Heart transplantation

View Full Paper

Ask AI

Bookmark

Implication

VEGF signaling may promote cardiac allograft arteriosclerosis in animals; leaves open whether receptor blockade could prevent chronic rejection in human recipients.

Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Vascular Endothelial Growth Factor Enhances Cardiac Allograft Arteriosclerosis

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider